Patent Assignment
Reel/Frame 028401/0655
Change of Name
Recorded: 2012-06-19
Pages: 8
Assignor
AGI THERAPEUTICS LIMITED
Executed: 2012-06-18
Assignee
AGI THERAPEUTICS PUBLIC LIMITED COMPANY
ADELAIDE CHAMBERS, PETER STREET, DUBLIN, 8, IRELAND
Covered Properties
(2)
Treatment of Abnormal Increases in Gastrointestinal Motility with (R)-Verapamil
METHODS AND COMPOSITIONS COMPRISING AT LEAST ONE ALPHA3 BETA4 nAChR ANTAGONIST OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
Application:
12/724,652 →
Publication:
US 2010/0196479
Related Assignments
(8)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 8, 2008
From: KEELING, P.N.W.; DINAN, TIMOTHY
To: AGI THERAPEUTICS RESEARCH LIMITED
Reel/Frame 020478/0544 →
Change of Name
Jun 19, 2012
From: AGI THERAPEUTICS RESEARCH LIMITED
To: VIDARA THERAPEUTICS RESEARCH LIMITED
Reel/Frame 028401/0563 →
Security Agreement
Jun 19, 2012
From: AGI THERAPEUTICS PUBLIC LIMITED COMPANY; VIDARA THERAPEUTICS RESEARCH LIMITED
To: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT
Reel/Frame 028401/0688 →
Release of Security Interest
Mar 17, 2014
From: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT
To: VIDARA THERAPEUTICS RESEARCH LIMITED; AGI THERAPEUTICS, LTD. (F/K/A AGI THERAPEUTICS PLC)
Reel/Frame 032452/0237 →
Security Interest
May 7, 2015
From: HORIZON PHARMA SERVICES LIMITED (FORMERLY KNOWN AS AGI THERAPEUTICS PUBLIC LIMITED COMPANY); HORIZON PHARMA IRELAND LIMITED (FORMERLY KNOWN AS VIDARA THERAPEUTICS RESEARCH LIMITED)
To: CITIBANK, N.A.
Reel/Frame 035590/0950 →
Change of Name
Aug 12, 2015
From: VIDARA THERAPEUTICS RESEARCH LIMITED
To: HORIZON PHARMA IRELAND LIMITED
Reel/Frame 036309/0919 →
Change of Name
Aug 12, 2015
From: AGI THERAPEUTICS LIMITED
To: HORIZON PHARMA SERVICES LIMITED
Reel/Frame 036309/0553 →
Release of Security Interest
Oct 6, 2023
From: CITIBANK, N.A.
To: HORIZON THERAPEUTICS IRELAND DAC (SUCCESSOR IN INTEREST TO HORIZON PHARMA SERVICES LIMITED); HORIZON THERAPEUTICS IRELAND DAC (FKA HORIZON PHARMA IRELAND LIMITED); HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.); HZNP LIMITED
Reel/Frame 065153/0953 →